The goal of this proposal is to develop a fundamental understanding of structure and function of the art gene of HTLV-III/LAV. This study is relevant to elucidation of fundamental genetic regulatory mechanisms that govern viral gene expression and which may also govern the expression of cellular genes in normal and in cancer cells. The study is also relevant to the design of novel classes of anti-AIDS drugs. The art gene is a recently discovered gene of HTLV-III that is thought to encode a protein needed for a late stage of viral production, specifically the synthesis of the viral capsid and envelope proteins. Virus genetically defective for the art gene are incapable of replication, an observation that implies that anti-art drugs should prevent viral growth and therefore be useful for anti-AIDS therapy.
Specific aims i nclude: 1. Physical characterization of the art gene product. 2. Investigation of the mechanism of action of the art gene. 3. Investigation of the active sites of the art gene product. 4. Developmetn of a rapid biochemical screen for anti-art drugs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA044460-03
Application #
3187074
Study Section
(SSS)
Project Start
1987-07-01
Project End
1992-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Gottlinger, H G; Dorfman, T; Cohen, E A et al. (1992) The role of the tnv protein and tnv RNA splicing signals in replication of HIV-1 IIIB isolates. Virology 189:618-28
Salfeld, J; Gottlinger, H G; Sia, R A et al. (1990) A tripartite HIV-1 tat-env-rev fusion protein. EMBO J 9:965-70
Cohen, E A; Dehni, G; Sodroski, J G et al. (1990) Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J Virol 64:3097-9
Lippitz, B E; Halperin, E C; Griffith, O W et al. (1990) L-buthionine-sulfoximine-mediated radiosensitization in experimental interstitial radiotherapy of intracerebral D-54 MG glioma xenografts in athymic mice. Neurosurgery 26:255-60
Cohen, E A; Lu, Y; Gottlinger, H et al. (1990) The T open reading frame of human immunodeficiency virus type 1. J Acquir Immune Defic Syndr 3:601-8
Rosenberg, M C; Colvin, O M; Griffith, O W et al. (1989) Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion. Cancer Res 49:6917-22
Dayton, A I; Terwilliger, E F; Potz, J et al. (1988) Cis-acting sequences responsive to the rev gene product of the human immunodeficiency virus. J Acquir Immune Defic Syndr 1:441-52